Podcast: Download (Duration: 13:13 — 15.1MB) | Embed
Subscribe: Spotify | Email | TuneIn | RSS | More
Alan Klitenic, director of Investor Relations for ChineseInvestors.com (OTCQB: CIIX) (the “Company”), called in to SmallCapVoice.com, Inc. to go over the business model, markets, milestones and 2017 outlook for the Company. Founded in 1999, ChineseInvestors.com, Inc. endeavors to be an innovative company providing (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) support services to various partners; (c) consultative services to smaller private companies considering becoming a public company; (d) advertising and public relation related support services; and (e) other services we may identify having the potential to create value or partnership opportunity with our existing services. Recently, the Company announced a new wholesale agreement that enables CIIX to retail nutritional supplements containing CBD to the Asian market through both online and in-store sales. The CBD company’s flagship product is the top-selling brand of hemp-derived CBD oil for consumers in the natural products industry.
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
